Eltrombopag 12.5 mg/1

Eltrombopag 12.5 mg/1 is a powder for oral suspension used to support blood cell production. This medication is commonly prescribed for conditions affecting platelet levels. Eltrombopag olamine helps manage low platelet counts in the blood.

Eltrombopag 12.5 mg/1 is primarily used to increase platelet production in individuals with certain blood disorders. This medication is often prescribed for conditions like immune thrombocytopenia (ITP), where the body does not produce enough platelets. Eltrombopag olamine works by stimulating the bone marrow to produce more platelets, which are essential for blood clotting. What is Eltrombopag used for? It is typically used to manage low platelet counts and reduce the risk of bleeding in eligible patients.

Common effects of Eltrombopag 12.5 mg/1 may include nausea, headache, and fatigue. Some users might experience dizziness or abdominal pain. These effects are generally mild and temporary. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Eltrombopag 12.5 mg/1 should be used with caution in individuals with liver problems or a history of blood clots. It is important to follow the prescribed dosage and administration instructions. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking.

Eltrombopag 12.5 mg/1 may interact with certain medications, including antacids and supplements containing calcium, magnesium, aluminum, selenium, iron, or zinc. It is also important to avoid taking this medication with other drugs that affect platelet production. Alcohol should be avoided as it may increase the risk of side effects. Always consult a healthcare provider before starting any new medication.